DNA X, Inc. 8-K

What Happened
DNA X, Inc. announced its financial results for the fiscal quarter ended December 31, 2025 via a press release issued on April 14, 2026. The company filed a Current Report on Form 8‑K with the SEC on April 15, 2026 to disclose the release; the press release is furnished as Exhibit 99.1 to the Form 8‑K.

Key Details

• Press release announcing quarterly results issued April 14, 2026.
• Form 8‑K reporting the release filed on April 15, 2026.
• Results cover the fiscal quarter ended December 31, 2025.
• Press release furnished as Exhibit 99.1 (and the Inline XBRL cover page file is included).

Why It Matters
This filing signals that DNA X has publicly released its quarterly earnings and other financial metrics (revenue, net income, cash flow, etc.) for the period ending December 31, 2025. Retail investors should review the press release (Exhibit 99.1) for the specific earnings, revenue figures, and any commentary on business trends or outlook, since those details drive valuation and near‑term trading decisions. The 8‑K itself does not present the numeric results — the press release does.